With this 100% online Master's Degree, you will equip yourself with specialized skills for the management of patients with hematologic diseases, applying the latest technological and scientific innovations” 

The role of nursing staff in hematology services has evolved significantly, with their participation in the management of therapies such as chemotherapy, immunotherapy and hematopoietic stem cell transplants standing out. In fact, according to the International Society of Hematology (ISH), specialized education in hematology for nurses is fundamental for improving clinical outcomes for patients and minimizing the adverse effects of treatment. 

This is how this Master's Degree was developed, designed to provide professionals with the knowledge and skills necessary to care for patients with hematological diseases in an efficient and compassionate manner. In this sense, the physiology and diseases of the blood and hematopoietic organs will be studied in depth, identifying and addressing both malignant and non-malignant diseases in pediatric and adult patients. 

Likewise, a distinction will be made between conventional and advanced therapies, acquiring tools to solve clinical cases and promote safe practices, both in the administration of medications and in the comprehensive management of patients. It will also explore aspects such as palliative care, addressing techniques for the control of refractory symptoms, effective communication in complex situations and emotional support for patients and families. 

Finally, expertise in ethics, digital transformation and research will be fostered, preparing experts to face ethical dilemmas, incorporate innovative technologies such as Artificial Intelligence and data analysis in clinical practice, and participate in clinical trials and scientific studies. 

In this way, TECH has implemented a syllabus of high academic quality, 100% online, which will only require an electronic device with an Internet connection to access all the teaching materials, avoiding problems such as traveling to a physical center or adjusting to a fixed schedule. In addition, it will use the revolutionary Relearning methodology, which consists of the reiteration of key concepts for an optimal and organic assimilation of the content. 

This multidimensional approach will integrate technical knowledge, interpersonal skills and an up-to-date vision of trends in hematological care, enabling you to improve the quality of life of your patients” 

This Master's Degree in Hematology Nursing contains the most complete and up-to-date scientific program on the market.The most important features include:

• The development of case studies presented by experts with a deep knowledge of detection and intervention techniques in Hematology Nursing, which facilitate the work of nurses in clinics, hospitals and other healthcare centers
• The graphic, schematic and practical contents with which it is conceived provide scientific and practical information on those disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning 
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection 

You will be qualified to carry out accurate clinical assessments, interpret diagnostic results and plan personalized care, applying advanced techniques such as chemotherapy and bone marrow transplants” 

The program’s teaching staff includes professionals from the sector who contribute their work experience to this specializing program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to prepare for real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will develop skills to apply prevention, diagnosis and treatment interventions in Hematology, in adults and children, thanks to an extensive library of innovative multimedia resources”

You will master advanced digital tools, such as the Electronic Health Record and Telemedicine, improving patient monitoring and facilitating more accurate diagnoses. What are you waiting for to enroll?”

This syllabus will combine theoretical knowledge of hematology physiology, disease and treatments with the development of practical skills in the management of advanced techniques such as chemotherapy and bone marrow transplant. In addition, essential areas such as prevention, diagnosis, palliative care and patient safety management will be included. Topics related to healthcare ethics, clinical research and digital transformation will also be covered, enabling nurses to integrate technological tools and actively participate in scientific advances. 

Upon completion, you will be better prepared to lead multidisciplinary teams, participate in clinical research and contribute significantly to improving health outcomes in Hematology” 

Module 1. Hematology Patients in Nursing

1.1. Hematologic Disease. Immune Reactions and Inflammation

1.1.1. Hematologic Diseases
1.1.2. Immune System in Hematologic Diseases
1.1.3. Inflammatory Process in Hematologic Diseases
1.1.4. Immune Reactions in Hematologic Diseases
1.1.5. Inflammation in Hematologic Diseases

1.2. Hematological System Assessment

1.2.1. Hematological System Physiology
1.2.2. Blood Groups
1.2.3. Key Signs and Symptoms in Emergencies

1.3. Alteration of Cell Growth: Cancer

1.3.1. Molecular Basis of Cancer
1.3.2. Cell Biology of Cancer
1.3.3. Molecular and Cytogenetic Diagnostic Techniques

1.4. Erythrocyte Disorders

1.4.1. Structure and Function of Erythrocytes
1.4.2. Erythropoiesis
1.4.3. Anemias, Polycythemia and Morphological and Functional Alterations of Erythrocytes
1.4.4. Diagnosis and Assessment of Erythrocyte Disorders

1.5. Leukocyte Disorders

1.5.1. Physiology and Function of Leukocytes
1.5.2. Leukopenia, Leukocytosis and Leukocyte Neoplasms
1.5.3. Diagnosis and Assessment of Leukocyte Disorders

1.6. Coagulation Disorders

1.6.1. Coagulation Physiology
1.6.2. Bleeding Disorders
1.6.3. Thromboembolic Disorders
1.6.4. Diagnosis and Assessment of Coagulation Disorders

1.7. Nursing in the Hematology Department

1.7.1. Treatment Protocol for Hematologic Diseases
1.7.2. Specialized Care in Hematology
1.7.3. Monitoring of Emergency Signs and Symptoms in Hematologic Diseases

1.8. Assessment of Patients with Chronic Diseases: Pain

1.8.1. Pain Assessment
1.8.2. Impact of Pain on Quality of Life
1.8.3. Pain Management
1.8.4. The Role of Nursing in Pain Assessment and Management

1.9. Adaptation and Coping with Hematologic Diseases

1.9.1. Development of Positive Coping Mechanisms
1.9.2. Support Networks and Effective Communication
1.9.3. Adaptation to Lifestyle Changes
1.9.4. Patient Education and Empowerment

1.10. Pediatric Hematology. Non-Malignant and Malignant Diseases in Children

1.10.1. Pediatric Hematology

1.10.1.1. Diagnosis and Laboratory Tests
1.10.1.2. Nursing Care
1.10.1.3. Research and Advances

1.10.2. Malignant Disease

1.10.2.1. Childhood Leukemia
1.10.2.2. Pediatric Lymphoma
1.10.2.3. Solid Hematologic Tumors
1.10.2.4. Management and Treatment of Malignant Disease

1.10.3. Non-Malignant Disease

1.10.3.1. Anemias
1.10.3.2. Coagulation Disorders
1.10.3.3. Autoimmune Diseases
1.10.3.4. White Blood Cell Disorders

Module 2. Hematological Prevention, Diagnosis and Treatment in Nursing

2.1. Prevention of Hematologic Diseases

2.1.1. Environmental Factors
2.1.2. Lifestyles: Stress Reduction. Diet
2.1.3. Vaccines and Infection Prevention
2.1.4. Periodic Medical Check-Ups. Early Symptom Detection
2.1.5. Education and Awareness
2.1.6. Genetic Counseling and Screening Tests
2.1.7. Adequate Management of Chronic Diseases. Vulnerable Populations

2.2. Prevention of Hematologic Diseases

2.2.1. Personal and Family History
2.2.2. Reason for Consultation and Current Disease
2.2.3. System Review
2.2.4. Blood Transfusions and Medication
2.2.5. Exposure to Risk Factors
2.2.6. Physical Examination

2.3. Diagnostic Assessment: Medical Tests

2.3.1. Laboratory Tests
2.3.2. Bone Marrow Biopsy
2.3.3. Bone Marrow Aspiration
2.3.4. Genetic and Molecular Studies
2.3.5. Imaging Tests

2.4. Interventions for Patients with Hematologic Disorders: Anemias

2.4.1. Hereditary Anemias
2.4.2. Acquired Anemias
2.4.3. Hemolytic Anemias

2.5. Interventions for Patients with Hematologic Disorders: Leukaemias

2.5.1. Acute Lymphoblastic Leukemia in Adults (ALL)
2.5.2. Chronic Lymphocytic Leukemia (CLL)
2.5.3. Acute Myeloid Leukemia (AML)
2.5.4. Chronic Myeloid Leukemia (CML)
2.5.5. Adult T-cell Leukemia (ATL)

2.6. Interventions for Hematology Patients: Coagulation Disorders

2.6.1. Bleeding Disorders (Hypocoagulability)
2.6.2. Thrombotic Disorders (Hypercoagulability)
2.6.3. Mixed Coagulation Disorders

2.7. Management of Patients with Bleeding Disorders

2.7.1. Assessment and Diagnosis
2.7.2. Management of Hemorrhages
2.7.3. Pharmacological Treatments
2.7.4. Nursing Care in Bleeding Disorders
2.7.5. Intervention in Special Situations

2.8. Hemotherapy. Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

2.8.1. Hematopoietic Stem Cell Transplantation
2.8.2. Donation and Collection Process
2.8.3. Preparing the Patient for Transplantation
2.8.4. Transplantation Procedure
2.8.5. Complications and Post-Transplantation Management
2.8.6. Nursing Care in Allogeneic Hematopoietic Stem Cell Transplantion

2.9. Therapies: Cytostatics, Radiotherapy, Immunotherapy

2.9.1. Cytostatics

2.9.1.1. Mechanisms of Action of Cytostatics
2.9.1.2. Side Effects and Management of Cytostatics
2.9.1.3. Cytostatic Administration Protocol
2.9.1.4. Resistance to Cytostatics
2.9.1.5. New Developments and Emerging Drugs

2.9.2. Radiotherapy

2.9.2.1. Treatment Planning
2.9.2.2. Side Effects of Radiotherapy
2.9.2.3. Radiotherapy in Hematology

2.9.3. Immunotherapy

2.9.3.1. Types of Immunotherapy
2.9.3.2. Adverse Effects and Management
2.9.3.3. Immunotherapy in Hematology

2.10. Pediatric Hematology

2.10.1. Pediatric Hematology
2.10.2. Hematologic Diseases in Pediatrics
2.10.3. Diagnosis and Treatment of Hematologic Diseases
2.10.4. Nursing Care in Pediatric Hematology

Module 3. Hematology Nursing Care Plans

3.1. Drug Administration

3.1.1. Routes of Administration of Chemotherapy and Immunotherapy
3.1.2. Types of Chemotherapy and Immunotherapy
3.1.3. Most Common Adverse Reactions
3.1.4. Management of Cytostatic Extravasation
3.1.5. Safe Preparation and Handling of Drugs

3.2. Administration of Blood Products

3.2.1. Types of Blood Products
3.2.2. Acute and Delayed Transfusion Reactions
3.2.3. Special Considerations: Pediatric and Geriatric Patients and Patients with Cardiovascular Diseases

3.3. Nursing Approach to the Nutrition of Hematology Patients

3.3.1. Changes in Intake
3.3.2. Assessment of Nutritional Status
3.3.3. Management of Digestive Disorders
3.3.4. Nutritional Support: Enteral and Parenteral

3.4. Care of the Skin and Mucous Membranes in the Care Process

3.4.1. Alterations of the Skin and Cutaneous Mucous Membranes
3.4.2. Prevention and Management
3.4.3. Psychosocial and Aesthetic Impact on Skin Disorders

3.5. Emergency Situations in Hematology Patients

3.5.1. Immunological Complications
3.5.2. Neutropenic Sepsis
3.5.3. Hemorrhagic Complications
3.5.4. Major Hemorrhage
3.5.5. Severe Thrombocytopenia
3.5.6. Acute Anemia
3.5.7. Metabolic Complications

3.5.7.1. Hypercalcemia
3.5.7.2. Tumor Lysis Syndrome

3.5.8. Vascular Complications

3.5.8.1. Hyperleukocytosis
3.5.8.2. Complications of Sickle Cell Disease

3.6. Hematopoietic Stem Cell Transplantation (HSCT)

3.6.1. Differences between Autologous and Allogeneic HSCT. Types e Indicators
3.6.2. Donor Selection and Inclusion Criteria
3.6.3. Obtaining Hematopoietic Stem Cells. Mobilization and Apheresis
3.6.4. Setting Up
3.6.5. Stem Cell Infusion
3.6.6. Post-Transplantion Phase: Follow-up and Care

3.7. Nursing Care in Hematopoietic Stem Cell Transplantation (HSCT)

3.7.1. Pre-transplant Preparation and Conditioning
3.7.2. Nursing Care During Stem Cell Infusion
3.7.3. Management of Post-Transplantion Aplasia
3.7.4. Complications in Stem Cell Transplantation
3.7.5. Graft-Versus-Host Disease (GVHD)
3.7.6. Complications caused by the Toxicity of the Conditioning Treatment
3.7.7. Infectious Complications
3.7.8. Infection Prevention in Hematopoietic Stem Cell Transplantation

3.8. CAR-T Cell Therapy

3.8.1. CAR-T Cell Therapy. Indications
3.8.2. Therapy Process. Obtaining CAR-T Cells
3.8.3. Possible Secondary Effects
3.8.4. Challenges for the Future

3.9. Psychological Approach to CAR-T Cell Therapy

3.9.1. Psychological Impact of Diagnosis and Treatment
3.9.2. Interventions in the Psychological Approach
3.9.3. Support as Part of the Holistic Process

3.10. Physical and Emotional Complications for the Patient and Family in CAR-T Cell Therapy

3.10.1. Management of Chronic Pain and Fatigue
3.10.2. Addressing Body Image Disturbances
3.10.3. Preventing Burnout in the Primary Caregiver

Module 4. Patient Safety in Hematology Nursing

4.1. Context and Components of Patient Safety in Hematology

4.1.1. Context of Patient Safety
4.1.2. “To Err is Human” Report
4.1.3. Taxonomy of Patient Safety
4.1.4. Concern for Patient Safety at the International Level
4.1.5. Nine Solutions for Patient Safety According to the WHO
4.1.6. Challenges and Improvement of Patient Safety

4.2. Prevention and Notification of Incidents: Adverse Events. Second Victims

4.2.1. Incident Reporting Systems. Structure
4.2.2. Medical Error: Crisis Management
4.2.3. Patient Information
4.2.4. Second Victims

4.3. Safe Clinical Practice. Non-Safety Costs in the Hematology Department

4.3.1. Internationally Recommended Safe Clinical Practices
4.3.2. Costs of Non-Patient Safety
4.3.3. The Culture of Patient Safety

4.4. Patient Safety in the Hematology Department. Importance of the Nurse

4.4.1. Nursing Staff as a Key Element in Patient Safety
4.4.2. Adverse Events in Nursing Practice
4.4.3. Burnout Syndrome as a Cause of Adverse Events
4.4.4. Safety in Hospital Services

4.5. Prevention of Healthcare-Associated Infection in the Hematology Department

4.5.1. Healthcare-Associated Infections (HAIs)
4.5.2. Transmission Mechanisms of HAIs
4.5.3. Environmental Biosafety
4.5.4. Endemic and Epidemic Infections

4.6. Hand Hygiene in the Hematology Department

4.6.1. Healthy Skin. Microorganisms: Skin Flora
4.6.2. The WHO's 5 Moments
4.6.3. Hygienic Washing vs. Washing by Friction
4.6.4. General Recommendations: Skin Care
4.6.5. Hand Hygiene Technique
4.6.6. Correct Use of Gloves

4.7. Antimicrobial Resistance in the Hematology Department

4.7.1. Safe Use of Medications
4.7.2. Antimicrobials and Classification
4.7.3. Antimicrobial Resistance
4.7.4. Antimicrobial Resistant Microorganisms
4.7.5. Antimicrobial Resistance. Control Strategies

4.8. Nursing Safety Rounds in the Hematology Department

4.8.1. Objectives of Patient Safety Rounds
4.8.2. Implementation of Patient Safety Rounds in the Hematology Department
4.8.3. Methodology: Scheduling, Preparation for the visit and Completion. Feedback
4.8.4. Checklist in the Rounds

4.9. Informed Consent in the Context of Data Protection

4.9.1. Components of Informed Consent. Revocation
4.9.2. The Nurse's Role in Informed Consent
4.9.3. Special Situations in Informed Consent

4.10. Therapeutic Effort Limitation

4.10.1. Reasons for Limiting Therapeutic Effort. Difficulties and Decision Making
4.10.2. Therapeutic Effort Limitation: Professionals and Patients
4.10.3. Ethical Framework

Module 5. Palliative Care for Patients with Hematological Cancer

5.1. Palliative Care for Terminally Ill Patients with Hematological Cancer

5.1.1. Palliative Care for Terminally Ill Patients with Hematological Cancer
5.1.2. Current Palliative Care
5.1.3. Quality of Life in Palliative Care

5.2. Recurrence: Treatment Options for Hematological Cancer

5.2.1. Types of Recurrence in Hematological Cancer
5.2.2. Treatment Options for Recurrences in Hematological Cancer
5.2.3. Palliative Care from the Onset of Recurrence to Manage Symptoms and Improve the Quality of Life of the Onco-Hematological Patient

5.3. Comprehensive Nursing Plan for the Palliative Patient with Hematological Cancer

5.3.1. Assessment of Physical Symptoms: Assessment, Control and Monitoring
5.3.2. Emotional Appraisals
5.3.3. Socio-Family, Cognitive, Functional and Spiritual Assessment

5.4. End of Life: Well-being and Dignity in the Patient with Hematological Cancer from the Nursing Service

5.4.1. Difference between Palliative Care and Terminal Care
5.4.2. Care in the Final Stage of Life. Compassionate Accompaniment
5.4.3. Emotional and Spiritual Care
5.4.4. Emotional and Bereavement Support for the Family

5.5. Scales for Assessing Palliative Needs in Children, Adolescents and Adults with Hematological Cancer

5.5.1. Assessment Scales for Hematological Patients in Palliative Care
5.5.2. Specific Tools for Symptom Assessment
5.5.3. Assessment Adapted to Different Stages of Life

5.6. Nursing Care for Palliative Patients with Hematological Cancer

5.6.1. Signs and Symptoms in the Terminally Ill Patient
5.6.2. Pharmacological Approach in Palliative Care
5.6.3. Non-Pharmacological Approach

5.7. Refractory Symptoms in Palliative Care in Patients with Hematological Cancer

5.7.1. Refractory Symptoms and Other Common Symptoms
5.7.2. Interventions and Management
5.7.3. Care in the Hematological Context

5.8. Nursing Care during the Terminal Phase and the Situation in the Final Days of Patients with Hematological Cancer

5.8.1. Agony Phase or Situation in the Final Days
5.8.2. Palliative Sedation and Comfort Care
5.8.3. Role of the Multidisciplinary Team

5.9. Palliative Care Services at Different Health Levels

5.9.1. Evolution of Palliative Care Teams (PCTs)
5.9.2. Care Network: Hospital versus Home Care
5.9.3. Integration of Palliative Care in Primary, Secondary and Tertiary Care

5.10. Psychosocial Aspects of Palliative Care in Patients with Hematological Cancer

5.10.1. Impact on the Family and Caregivers of Patients with Hematological Cancer
5.10.2. Family Claudication
5.10.3. Comprehensive Care: Fostering, Caring and Accompanying
5.10.4. Cultural and Spiritual Aspects
5.10.5. Communicating Bad News: Objectives of Nursing Staff

Module 6. Ethics in the Practice of Hematology Nursing

6.1. Bioethics

6.1.1. Background of Bioethics
6.1.2. Fundamentals in Bioethics
6.1.3. Political, Social, Economic and Cultural Events of the 20th Century that Contributed to the Development of Bioethics

6.2. Ethical Principles Focused on the Hematology Patient

6.2.1. Autonomy
6.2.2. Beneficence
6.2.3. Justice
6.2.4. Non-Maleficence

6.3. Hematology Patient Autonomy and Shared Decision Making

6.3.1. International Convention on Human Rights and Biomedicine
6.3.2. International Covenant on Economic, Social and Cultural Rights
6.3.3. International Laws on Patient Autonomy

6.4. Right to Information in the Healthcare Environment of the Hematology Patient

6.4.1. Patient Rights
6.4.2. Right to Information in the Healthcare Field
6.4.3. Role of the Nursing Professional: Patient Confidentiality

6.5. Advance Directives and Living Wills in Relation to Healthcare

6.5.1. Advance Directives and Living Wills of the Hematology Patient
6.5.2. Living Will and Advance Directives of the Hematology Patient
6.5.3. Ethical Dilemmas in the Application of Living Wills

6.6. Euthanasia in the Hematology Patient

6.6.1. Euthanasia in the Hematology Patient
6.6.2. International Laws and Regulatory Bases
6.6.3. Right to Conscientious Objection

6.7. Blood Transfusions in the Treatment of Hematology Patients

6.7.1. Administration of Blood Transfusions in Hematology Patients
6.7.2. International Regulations on the Administration of Blood Transfusions
6.7.3. Religious Beliefs and Their Impact on the Refusal of Blood Transfusions

6.8. Refusal of Treatment in Hematology Patients

6.8.1. International Legislation on the Right to Refuse Treatment
6.8.2. Refusal of Treatment in Vulnerable Patients
6.8.3. Ethical and Legal Implications in Critical Situations

6.9. International Committees on Clinical Research and Healthcare Ethics

6.9.1. International Experiences in Clinical Consulting
6.9.2. Deliberation in International Committees on Healthcare Ethics: Courses of Action
6.9.3. International Clinical Research Committees

6.10. Responsibility in the Nursing Profession

6.10.1. International Regulations on Professional Practice
6.10.2. The Importance of Ethics and Legislation in Nursing
6.10.3. Challenges and Opportunities in Nursing Responsibility

Module 7. Relationship with the Hematology Patient

7.1. Humanization of Hematology Patient Care in Nursing

7.1.1. Humanization, Therapeutic Relationship
7.1.2. Evolution of the Nurse-Patient Relationship
7.1.3. Importance of Humanization in Nursing Care

7.2. Humanization Tools and Techniques in Daily Nursing Practice

7.2.1. Active Listening
7.2.2. Verbal and Non-Verbal Communication
7.2.3. Impact of Empathy on the Relationship with the Patient

7.3. Models of Nurse-Patient Bonding and Relationship

7.3.1. Nursing Models
7.3.2. Holistic Model of Care
7.3.3. Traditional and Humanized Models. Comparison
7.3.4. Nurse-Patient Relationship in Today's Nursing

7.4. Humanized Environments (I): Grief and Support for Hematology Patients in the Nursing Department

7.4.1. Stages of Grief
7.4.2. Physical and Emotional Consequences
7.4.3. Importance of Grief Support

7.5. Humanized Environments (II): Relationship between the Health Team, Patient and Family

7.5.1. Role of the Patient in Shared Decision Making
7.5.2. Impact of the Disease on the Family
7.5.3. Communication between the Health Team, the Patient and the Family

7.6. Support Network and Resources for the Well-being and Satisfaction of Patients and Families

7.6.1. Family Therapy and Support Groups
7.6.2. Strategies for Emotional Support for Families
7.6.3. Support Networks and Resources

7.7. Nurse-Hematology Patient Relationship in Terminal Situations. Personalized Care

7.7.1. Nurse-Hematology Patient Relationship in Terminal Situations
7.7.2. Management of Patient Needs
7.7.3. Compassionate and Personalized Care

7.8. Care Burden and Impact on the Nurse-Patient Relationship in Care

7.8.1. Care Burden
7.8.2. Dehumanization in Health Systems
7.8.3. Impact of Care Burden on Quality of Care

7.9. Self-Care in Nursing Professionals: Stress and Emotion Management in Multidisciplinary Teams

7.9.1. Time Management Techniques
7.9.2. Prioritization of Tasks and Care
7.9.3. Fostering Teamwork and Interdisciplinary Collaboration
7.9.4. Training in Stress Management Skills

7.10. Self-Care Strategies in Nursing Professionals

7.10.1. Strategies for Self-Help and Self-Care
7.10.2. Working in Humanized Hospital Environments
7.10.3. Importance of Supervision and Support
7.10.4. Implementation of Healthy Boundaries

Module 8. Digital Transformation in the Hematology Department in Nursing

8.1. Electronic Health Records (EHR) for Hematology Patients

8.1.1. Implementation and Management of Electronic Health Records (EHR)
8.1.2. Benefits and Challenges of Electronic Health Records (EHR) in Hematology
8.1.3. Data Security and Privacy in Electronic Health Records (EHR)

8.2. Telemedicine and Teleconsultation in the Hematology Department

8.2.1. Use of Telemedicine in the Follow-up of Hematology Patients
8.2.2. Tools and Platforms for Teleconsultations
8.2.3. Success Stories and Best Practices

8.3. Artificial Intelligence and Big Data in the Nursing Department

8.3.1. Applications of AI in the Diagnosis and Treatment of Hematologic Diseases
8.3.2. Analysis of Large Volumes of Data for Research and Improvement of Treatments
8.3.3. Ethics and Use of AI and Big Data in Healthcare

8.4. Remote Monitoring of Hematology Patients by Nurses

8.4.1. Devices and Technologies for Remote Monitoring
8.4.2. Integration of Monitoring Data in Clinical Practice
8.4.3. Impact on the Quality of Life of Hematology Patients

8.5. 3D Printing and Simulation Models for Nursing Service Training

8.5.1. Bioprinting: Current and Future Applications in Hematology
8.5.2. Use of 3D printing in the Creation of Anatomical Models for Treatment Planning
8.5.3. Virtual Simulations for the Education and Training of Nursing Staff

8.6. Mobile Apps and mHealth for Monitoring Hematology Patients

8.6.1. Development and Use of Mobile Applications for the Monitoring of Hematology Patients
8.6.2. Evaluation of the Effectiveness of Health Apps in Hematology
8.6.3. Health Promotion and Patient Education through mHealth

8.7. Gamification in Education and Treatment Adherence in the Hematology Department

8.7.1. Use of Gamification Techniques to Improve Adherence to Treatment
8.7.2. Educational Games and Applications for Patients and Healthcare Professionals
8.7.3. Future Trends in Gamification

8.8. Augmented Reality (AR) and Virtual Reality (VR) for the Treatment of Hematologic Diseases from the Nursing Department

8.8.1. AR Applications in Nursing Training
8.8.2. VR Applications in Nursing Training
8.8.3. Use of AR and VR for the Visualization of Complex Procedures

8.9. Cybersecurity in Healthcare

8.9.1. Principle of Cybersecurity in the Healthcare Environment
8.9.2. Cybersecurity Practices in the Healthcare Environment
8.9.3. Protection of Patient Information and Regulatory Compliance

8.10. Future Trends in Digital Transformation in the Hematology Department

8.10.1. Emerging Innovations and their Potential Impact
8.10.2. Preparing Nursing Staff to Adapt to New Technologies
8.10.3. Automation of Clinical Processes in Hematology

Module 9. Research and Clinical Trials in Hematology Nursing

9.1. Phases in the Development of a Drug

9.1.1. Discovery and Development
9.1.2. Preclinical and Clinical Phase
9.1.3. Registration, Launch and Monitoring
9.1.4. Post-Launch Actions

9.2. Clinical Trials in Hematology

9.2.1. Clinical Trials
9.2.2. Multidisciplinary Team
9.2.3. Responsibilities of the Research Team

9.3. Classification of Clinical Trials in Hematology

9.3.1. Types of Clinical Trials in Hematology
9.3.2. Phases of Clinical Trial (CT)
9.3.3. Representation of the Current Situation

9.4. International Regulation of Clinical Trials

9.4.1. Specific and Current International Legislation
9.4.2. The Declaration of Helsinki and Standardized Procedures for Good Clinical Practice
9.4.3. International Regulatory Framework

9.5. Clinical Trials Management in the Hematology Department

9.5.1. Origin of a Clinical Trial
9.5.2. Screening, Recruitment and Inclusion of Patients
9.5.3. Contractual Relationship between the Subjects of the Trial
9.5.4. Early Termination or Suspension of the Clinical Trial

9.6. Monitoring of Clinical Trials (CT) in Hematology

9.6.1. Monitoring Objectives
9.6.2. Deviations
9.6.3. Pharmacovigilance in Clinical Trials

9.7. Follow-up of Patients in Clinical Trials in Hematology

9.7.1. Data Collection and Management
9.7.2. Data Protection and Confidentiality
9.7.3. Strategies for Keeping Patients in Clinical Trials

9.8. Observational Studies in Hematology

9.8.1. Observational Studies in Hematology
9.8.2. Current Status of Clinical Trials
9.8.3. Clinical Trials vs. Observational Studies

9.9. Financial Implications of Clinical Research

9.9.1. Economic Impact of Clinical Trials (CT) on the Health System
9.9.2. Economic Analysis of Clinical Trials: Costs and Benefits
9.9.3. Funding of Clinical Trials

9.10. Audits and Inspections: Pillars of Clinical Trial Integrity

9.10.1. Clinical Research Ethics Committee
9.10.2. Difference between Audit and Inspection
9.10.3. Objectives of Inspections and Audits

Module 10. Update on the Hematology Nursing Department

10.1. Update on the Hematology and Hemotherapy Department

10.1.1. Structure of a Hematology and Hemotherapy Unit

10.1.1.1. Cytostatic Preparation Cabinet
10.1.1.2. Transplant Unit
10.1.1.3. Blood Bank
10.1.1.4. Negative Pressure Rooms
10.1.1.5. Medication Preparation Area
10.1.1.6. Laboratory

10.1.2. Roles and Responsibilities in the Multidisciplinary Team in a Hematology Unit
10.1.3. Innovative Teaching and Learning Strategies in Hematology

10.2. Update on the Role of the Nursing Unit in the Hematology Department

10.2.1. Update on the Role of the Nursing Unit in the Hematology and Hemotherapy Department
10.2.2. Common Nursing Techniques in the Hematology Department
10.2.3. Responsibilities of Nursing Professionals in the Hematology and Hemotherapy Department

10.3. Standardized Protocols for Procedures to Improve Efficiency and Quality in the Hematology Department

10.3.1. Protocols for Administration of Chemotherapy
10.3.2. Protocols for Central and Peripheral Catheter Care
10.3.3. Protocols for Blood Sample Collection
10.3.4. Protocols for Post-Bone Marrow Transplant Care

10.4. Importance of the Nursing Approach to the Efficiency and Quality of the Hematology Service and Opportunities for Improvement

10.4.1. Critical Points and Margins for Improvement in Efficiency and Quality in the Hematology Department
10.4.2. Professional Development and Empowerment of a Hematology Nurse
10.4.3. Key Strategies for the Prevention of Complications in the Hematology and Hemotherapy Department

10.5. Intra-Hospital Support Services Referrals from the Nursing Department to Other Services and Specialties

10.5.1. Resolution of Referrals
10.5.2. Supervision of the Treatment and Transfusion of Blood Products
10.5.3. Resolution and Education in the Management of Hematologic Complications

10.6. Teamwork in the Hematology Nursing Department to Improve Efficiency and Quality in Patient Care

10.6.1. Nursing Teamwork in the Hematology Department to Improve Efficiency and Quality of Performance
10.6.2. Nursing Teamwork Strategies in the Hematology Department
10.6.3. Interdisciplinary Communication as a Key Element for Teamwork Among Nursing Professionals

10.7. Update on the Hematology Day Hospital

10.7.1. Structure of the Hematology Day Hospital
10.7.2. Functioning of the Hematology Day Hospital
10.7.3. Benefits of the Hematology Day Hospital

10.8. Clinical Sessions in Hematology. Methodology

10.8.1. Clinical Sessions in Hematology
10.8.2. Purpose of Clinical Sessions in Hematology

10.8.2.1. Case Analysis to Optimize Therapeutic Decisions

10.8.3. Methodology for Building an Effective Clinical Session

10.9. Support Associations for Patients with Hematological Cancer

10.9.1. Association Types
10.9.2. Functions of Support Associations for Patients with Hematological Cancer
10.9.3. Impact of Associations on Patients and their Families

10.10. Update on Oncohematological Nursing Consultations

10.10.1. Update on Oncohematological Nursing Consultations
10.10.2. Common Procedures in Oncohematological Nursing Consultations
10.10.3. Health Education in the Hematology Department

You will cover everything from the basic aspects of blood physiology and pathology to the application of advanced techniques in the management of diseases such as leukemia, lymphoma and other hematological disorders”